Optimum Profesorskie Centrum Okulistyki Sp. z o.o.

Gdansk 12 trials 3 recruiting

12 Registered trials

3 Currently recruiting

Organisation

Optimum Profesorskie Centrum Okulistyki Sp. z o.o.

Location

Gdansk, Poland

Identifier

ORG-100045078

Address

Ul. Warszawska 20, 80-180, Poland

Departments

2204; opthalmology
2204:Ophthalmology
6160020: ophtalmology
N/A
NA
NAP
Ophtalmology
Ophthalmology

Clinical trials at this site (12)

Search interface

A trial to investigate teprotumumab mg/ml subcutaneous administration compared with placebo in male and female adult participants with moder… Recruiting

2024-515702-63-00 Moderate-to-Severe Active Thyroid Eye Disease 5 2025-02-20
LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose) in the Treatment of … Recruiting

2024-513356-15-00 Acquired Blepharoptosis 5 2024-12-30
A Phase 1/2 Study to Assess AMG 732 in Healthy Subjects and Subjects with Thyroid Eye Disease Recruiting

2024-514110-12-00 Thyroid Eye Disease 7 2025-10-22
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF Ended

2025-520809-12-00 Diabetic Macular Edema 10 2025-10-16
A Safety, and Tolerability Study of VRDN-003 in Participants with Thyroid Eye Disease (TED) Ended

2024-519417-57-00 Thyroid eye disease 5 2025-06-25
A Phase 3 Study of Brepocitinib in Adults with Active, Non-Infectious, Non-Anterior Uveitis (CLARITY) Ended

2024-515089-15-00 active non-infectious uveitis (intermediate uveitis, po 5 2025-02-28
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF (in patients with Diabetic Macular Edema… Ended

2024-510944-30-00 Diabetic Macular Edema 10 2024-11-22
An open-label study for participants who are non-responders at the end of treatment assessment on the VRDN-001-101 and VRDN-001-301 pivotal … Ended

2023-507350-33-00 Thyroid eye disease 5 2024-06-25
A Safety, Tolerability and Efficacy Study of VRDN-001 in Persons with Chronic Thyroid Eye Disease (TED) Ended

2023-507217-10-00 Thyroid eye disease 5 2024-04-12
A study to learn how well a higher amount of aflibercept given as an injection into the eye works and how safe it is in people with reduced … Ended

2022-502174-16-00 Macular edema secondary to retinal vein occlusion 5 2023-09-13
A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension Ended

2022-502380-37-00 Open-Angle Glaucoma 5 2019-08-02
A Clinical Trial to compare Efficacy, Safety, Tolerability of RBS-001 to Eylea® in Subjects with Neovascular Age-Related Macular Degeneratio… Ended

2023-509206-29-00 Neovascular age-related macular degeneration (nAMD) 5